StageAsset Sale | AssetsPurchased
PathoGenetix, formerly U.S. Genomics, is developing an automated system for identification and strain typing of pathogens in a broad range of complex sample types. Unlike approaches that require specific reagents for detection of each pathogen, PathoGenetix' approach uses a single reagent set to create genomic barcodes which are then used to detect and identify thousands of strains from hundreds of species. No PCR or other amplification technique is applied. The company was founded in 2014 and is based in Watertown, Massachusetts.
Missing: PathoGenetix's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: PathoGenetix's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing PathoGenetix
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
PathoGenetix is included in 2 Expert Collections, including Omics.
Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
PathoGenetix has filed 11 patents.
Fluid dynamics, Continuum mechanics, Deformation (mechanics), Apple cultivars, Elasticity (physics)
Fluid dynamics, Continuum mechanics, Deformation (mechanics), Apple cultivars, Elasticity (physics)
Latest PathoGenetix News
Apr 28, 2022
Vori Health Transforms Back And Joint Pain Treatment READ MORE Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio READ MORE First U.S. Patient Enrolled in Cardionomic's CPNS Pilot Study READ MORE Recovery Centers of America (RCA) Partners with Owl to Deliver Highly Optimized Clinical Treatment for Patients with Substance Use Disorders READ MORE PursueCare Partners With Owl to Improve Behavioral Health Outcomes for Patients with Substance Use Disorders READ MORE Bardy Diagnostics Carnation Ambulatory Monitor Patch decreases both time to diagnosis and readmissions in Emergency Department patients with possible arrhythmia concerns in Clinical Study from Overlake Medical Center READ MORE Value-Based Payment Edges into Employer Programs READ MORE Post-COVID value-based platforms are ready to scale READ MORE Owl Launches New Brand and Adds Industry Leaders to Executive Team READ MORE CSA Medical Announces Enrollment Milestone in a Mechanism of Action Study utilizing the RejuvenAir® System for COPD Patients with Chronic Bronchitis READ MORE Community Psychiatry Doubles Facility Count, Becomes Bi-Coastal With Latest Acquisition READ MORE How Investors Evaluate Human Capital At Deal Stage READ MORE Strive Health Raises $140 Million Led by Alphabet’s CapitalG to Tackle $410 Billion of Unmanaged Kidney Disease Spend READ MORE Ascension Ventures finalizes fifth strategic healthcare venture fund; expands assets under management to more than $1 Billion READ MORE AdventHealth Selects Cedar Gate Technologies as Commercial Bundled Payments Partner READ MORE Blue Cross NC Launches Blue Premier Advanced Kidney Care in Collaboration with Fresenius Medical Care North America, Strive Health READ MORE Hillrom Announces Planned Acquisition Of Bardy Diagnostics, Inc. READ MORE IVANTIS RECOGNIZED FOR INNOVATION, EXCELLENCE AND COMPANY CULTURE READ MORE Top Workplaces: Ivantis brings tech smarts, equity share to its team READ MORE CSA Medical Announces Enrollment Milestone in a Mechanism of Action Study utilizing the RejuvenAir® System for COPD Patients with Chronic Bronchitis READ MORE eConsult Solution Company AristaMD Adds Ascension Ventures and .406 Ventures to Investment Syndicate, Completing Its $24 Million Series B Financing READ MORE Owl Insights Secures Strategic Investment Co-led by Ascension Ventures & Blue Venture Fund READ MORE Geisinger Partners with VisitPay as Importance of Patient Billing Experience Peaks Amid Economic Downturn READ MORE HUMANA AND STRIVE HEALTH ANNOUNCE KIDNEY DISEASE CARE COORDINATION SERVICES COLLABORATION IN KENTUCKY AND INDIANA READ MORE Cedar Gate Technologies Acquires Citra Health Solutions READ MORE TransUnion Partners with VisitPay to Extend Leading Healthcare Revenue Protection® Solutions into Patient Payments READ MORE Jacksonville patient receives first of its kind wireless pacemaker in Northeast Florida READ MORE Cedar Gate Technologies Announces Strategic Investment from Ascension Ventures READ MORE At one health system, self-service portal now accounts for 28% of collections READ MORE Ascension Health Moves to Connect to Home-Based Patients to Highly Interventional Telehealth Services READ MORE Cedar Gate Technologies’ Value-Based Care Analytics Help Franciscan ACO Improve Performance by $44.4 Million. READ MORE North Carolina taps Phreesia to help with social determinants of health READ MORE EBR Systems Closes $30M in New Funding, John McCutcheon Joins Company as President and CEO READ MORE Cedar Gate Technologies Recognized in Gartner's Hype Cycle for U.S. Healthcare Payers, 2019 Report READ MORE EBR Appoints Ascension Physician as Co-Principal Investigator READ MORE Ascension Ventures Completes Investment in Strive Health READ MORE Communications platform gains efficiencies, cuts discharge time at Avera Health READ MORE Renovia Appoints Tara Butler, M.D. to its Board of Directors READ MORE New KLAS Report Reveals Vivify Health's Platform as Most Discussed Remote Patient Monitoring Solution by Healthcare Providers READ MORE Renovia Completes $42.3 Million Series B Financing READ MORE HealthMyne Raises $15 Million in Series B Round to Expand Commercialization Efforts READ MORE Olive (f/k/a CrossChx) Closes $32.8 Million Series D Financing READ MORE Nation's First-Ever On-Demand Health Insurance Has Arrived READ MORE Remote care monitoring in Ascension Indiana and Ascension Texas enables greater access to care READ MORE New Data from the HORIZON Trial of the Hydrus® Microstent Shows Significantly Lower IOP and Medication Use at 24 Months in a US Patient Cohort READ MORE What Can VisitPay Do That Credit Cards Can’t? Understand When Patients Will Pay Their Hospital Bills READ MORE Precision medicine startup Syapse raises $30 million to expand cancer tech, S.F. workforce READ MORE Focusing on consumerization of healthcare billing, VisitPay closes $15M Series A READ MORE BardyDx Selected as one of CIOReview Magazine 10 Most Promising Patient Monitoring Solution Providers for 2017 READ MORE iVinci Health Rebrands as VisitPay and Raises Funds to Fuel Growth for Patient Financial Health Platform READ MORE R1 RCM and Phreesia Announce Strategic Partnership to Create a Better Patient Experience across the Continuum of Care READ MORE Cofactor Genomics Announces $18M Funding in an Oversubscribed Series-A Round to Bring RNA to Precision Medicine READ MORE Augmenix Announces Positive Five-Year Long-Term Data Highlighting Significant Bowel and Sexual Quality of Life Benefits for Prostate Cancer Patients Treated with SpaceOAR® Hydrogel READ MORE Augmenix is ranked number 207 on the INC 500 list of fastest growing private companies in America READ MORE CSA Medical Announces FDA (510K) clearance of truFreeze® System, RapidAV spray catheter READ MORE Neuronetics, Inc. Raises $15 Million in Series G Equity Financing, Led by Ascension Ventures READ MORE CSA Medical Announces Expansion of truFreeze® Label to Include Barrett’s Esophagus with High Grade Dysplasia READ MORE Recognizing the top workplaces in healthcare - Phreesia READ MORE New treatment helps prostate cancer patients READ MORE Vivify Health Awarded Patent for Extending EMRs with Digital Health READ MORE Home Health Agency Turns to Telemonitoring to Reduce Readmission Rates and Decrease Costs READ MORE Trinity to expand advanced home health telemedicine system READ MORE Hospital-based venture funds bet big on health startups READ MORE Novant Health Chooses Voalte Platform for Caregiver Communication at 14 Hospitals in 4 States READ MORE Iron Bow Technologies, Partnered with Vivify Health, Awarded $258 Million U.S. Veterans Affairs Home Telehealth Contract READ MORE Trinity Health at Home goes big with Vivify remote monitoring READ MORE Reputation.com Accelerates Growth with $20M Investment Led by Strategic Healthcare Fund READ MORE Bardy Diagnostics Announces Growth Capital Funding READ MORE GetWellNetwork Acquires Skylight Healthcare Systems READ MORE KLAS Rates Voalte Top Platform Vendor for Improved Care Team Communication READ MORE Dignity Health and Catholic Health Initiatives Team Up to Launch the Largest Community-Based Precision Medicine Program in the U.S. READ MORE Intermountain, Stanford, Providence form 79-hospital alliance to share cancer data READ MORE How technology is driving research in health care READ MORE Quantros, Inc. Acquires Comparion Medical Analytics READ MORE Invest for Health’ Sessions Announced for SXSW Interactive Festival READ MORE EBR Systems Announces First Commercial Implants of WiSE Technology READ MORE UPMC leads $17M investment in Vivify Health for its remote patient monitoring system READ MORE Ascension Ventures to Co-host SXSW Event READ MORE Syapse Raises $25 Million Series C Round Led by Ascension Ventures to Expand Precision Medicine READ MORE Ascension subsidiary becomes lead investor in virtual care: 3 things to know READ MORE Zipnosis Announces $17 Million Series A Financing Led By Safeguard Scientifics READ MORE Ingenious Med Ranked Number 341 Fastest Growing Company READ MORE Ascension Ventures Makes Strategic Investment in Atigeo READ MORE Voalte Raises $17 Million in Series D Financing READ MORE Cardinal Health to Acquire naviHealth,Leader in Post-Acute Care Management Solutions READ MORE One by Ingenious Med Secures #1 Ranking from KLAS READ MORE Apama Medical Closes $17.5M in Series B Financing READ MORE Leading Healthcare VC Firms to Invest in Ingenious Med READ MORE Phreesia Secures $30 Million in Funding Led by LLR Partners to Continue Expansive Growth and Maintain Market Leadership READ MORE Ocular Therapeutix Announces Closing of Initial Public Offering READ MORE Marshfield Food Safety Shows Increased Accuracy in Salmonella Strain Typing with PathoGenetix RESOLUTION System READ MORE PathoGenetix Delivers Bacterial Identification System to FDA for Evaluation READ MORE CSA Medical Completes $16 Million Series C Financing READ MORE ISTO Technologies names George W. Dunbar, Jr. President and Chief Executive Officer READ MORE Rapid Pathogen Identification System Evaluated for Food Industry Testing READ MORE Syapse Enters Strategic Collaboration with Roche to Advance Precision Medicine in Oncology READ MORE PathoGenetix Announces $10 Million Series C Financing READ MORE Quantros Secures Growth Investment from Acension Health Ventures READ MORE GetWellNetwork Receives Strategic Investment from Ascension Health Ventures READ MORE PathoGenetix Advances Commercialization of New RESOLUTION Microbial Genotyping System for Rapid Bacterial Serotyping and Strain Typing READ MORE Vivify Health Receives Funding to Accelerate Availability of its Cloud-based Remote Care Management Platform READ MORE naviHealth Receives Strategic Investments from BlueCross BlueShield Venture Partners and Ascension Health Ventures READ MORE CSA Medical Announces Completion of Enrollment in Mechanism of Action Study utilizing the RejuvenAir® System for COPD Patients with Chronic Bronchitis READ MORE
PathoGenetix Frequently Asked Questions (FAQ)
When was PathoGenetix founded?
PathoGenetix was founded in 2014.
Where is PathoGenetix's headquarters?
PathoGenetix's headquarters is located at 580 Pleasant Street, Watertown.
What is PathoGenetix's latest funding round?
PathoGenetix's latest funding round is Asset Sale.
How much did PathoGenetix raise?
PathoGenetix raised a total of $117.71M.
Who are the investors of PathoGenetix?
Investors of PathoGenetix include Toxic Reports, Excel Venture Management, Ascension Ventures, CB Health Ventures, Still River Funds and 15 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.